Dysrhythmias III: Characteristics of Dysrhythmias
Disturbances in Heart Rhythm
Pharmacodynamics in Geriatric Patients: Effects of Age
Drug Dosing: Geriatric Patients
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Dysrhythmias II: Classification of Tachyarrhythmias
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Apr 26, 2026

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
This review examines the rising prevalence of atrial fibrillation in older adults, explores potential links to obesity, and discusses modern treatment options like new oral anticoagulants to manage associated risks such as stroke.
Area of Science:
Background:
No prior work had fully resolved why heart rhythm irregularities are becoming more frequent among older populations. It was already known that this specific cardiac condition represents the most common arrhythmia seen by physicians. That uncertainty drove researchers to investigate the rapid growth of these cases over recent decades. Prior research has shown that some experts describe this trend as an emerging epidemic. This gap motivated a closer look at the potential environmental drivers behind such a widespread health shift. Scientists have observed that body mass index trends often mirror the rise in these cardiac events. Prior studies suggest that many elderly patients experience few noticeable symptoms, leading to significant underdiagnosis. This context highlights the urgent need to understand the factors contributing to the current clinical landscape.
Purpose Of The Study:
The aim of this review is to evaluate the current epidemiologic aspects of this common cardiac arrhythmia. Researchers seek to clarify why the prevalence of this disorder has increased so dramatically among older adults. The study addresses the uncertainty regarding the environmental factors that might drive this clinical trend. Specifically, the authors investigate whether rising obesity rates correlate with the observed surge in cardiac cases. The work also intends to summarize the risks associated with the condition, such as stroke and heart failure. A secondary goal involves discussing the therapeutic landscape for managing these patients. The authors pay particular attention to the role of new oral anticoagulants in modern practice. This effort provides a synthesized view of the challenges faced by clinicians treating an aging population.
Main Methods:
The authors utilized a comprehensive literature synthesis to evaluate existing data on cardiac rhythm disorders. This review approach focused on identifying trends in patient demographics and clinical outcomes. Investigators gathered information from various studies to map the rising prevalence of the condition. The team examined the potential correlation between metabolic health markers and cardiac stability. They assessed current therapeutic guidelines to determine the efficacy of modern pharmaceutical interventions. The evaluation process involved comparing traditional management strategies against newer pharmacological options. Researchers synthesized evidence regarding the frequency of unrecognized cases in older populations. This systematic inquiry provided a clear overview of the current state of clinical knowledge.
Main Results:
The strongest finding indicates that the incidence of this arrhythmia has risen constantly over the last several decades. Data suggest that obesity has played a significant role in the proliferation of these cases. The literature confirms that the disorder is frequently pauci-symptomatic in older individuals, leading to frequent underdiagnosis. Evidence shows that the condition carries a high risk of thrombo-embolic events, specifically strokes. The review highlights that untreated patients face a higher mortality rate compared to those receiving appropriate care. Findings demonstrate that the disorder often leads to heart failure if not managed effectively. The synthesis shows that new oral anticoagulants are a focus of modern therapeutic discussions. The results emphasize that the reasons for the rapid increase in prevalence are not entirely elucidated.
Conclusions:
The authors propose that the rising burden of this arrhythmia requires careful clinical management in aging populations. They suggest that obesity likely contributes to the observed increase in patient numbers. The review highlights that thrombo-embolic complications remain a primary concern for those diagnosed with the condition. New oral anticoagulants offer a modern approach to reducing stroke risk compared to older therapeutic strategies. The synthesis indicates that heart failure remains a major long-term consequence of untreated rhythm disorders. Experts emphasize that early detection is vital because many elderly individuals present with minimal symptoms. The analysis confirms that the interplay between metabolic health and cardiac stability requires further investigation. These findings imply that current medical practices must adapt to the shifting demographic and health profiles of patients.
The researchers propose that the condition often remains silent in older patients, which increases the likelihood of severe outcomes like strokes or heart failure. Unlike younger populations, elderly individuals frequently exhibit few symptoms, making early clinical identification difficult.
The authors suggest that obesity may act as a significant driver for the rising incidence of this heart rhythm disorder. While both conditions have increased in prevalence simultaneously, the exact biological pathways linking excess body weight to cardiac instability remain under investigation.
The review indicates that new oral anticoagulants are now preferred for managing thrombo-embolic risks. These modern medications provide an alternative to traditional therapies, aiming to lower the probability of stroke in patients who have already developed the arrhythmia.
The researchers note that the condition is frequently pauci-symptomatic, meaning patients show very few signs of illness. This lack of clear physical indicators often results in the disorder going unrecognized until a major event occurs.
The authors state that this arrhythmia is associated with a higher mortality rate and an increased risk of thrombo-embolic events. If left unmanaged, the disorder can progress to heart failure, severely impacting the long-term health of the aging population.
The researchers suggest that the rapid increase in cases constitutes an emerging epidemic. This classification is based on the constant rise in incidence and prevalence observed over the last several decades in clinical practice.